Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Ethnopharmacol ; 309: 116377, 2023 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-36907477

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Tea (Camellia sinensis) has been consumed for centuries as traditional medicine for various diseases, including diabetes. The mechanism of action of many traditional medicines, including tea, often requires elucidation. Purple tea is a natural mutant of Camellia sinensis, grown in China and Kenya, and is rich in anthocyanins and ellagitannins. AIM OF THE STUDY: Here we aimed to determine whether commercial green and purple teas are a source of ellagitannins and whether green and purple teas, purple tea ellagitannins and their metabolites urolithins have antidiabetic activity. MATERIALS AND METHODS: Targeted UPLC-MS/MS was employed to quantify the ellagitannins corilagin, strictinin and tellimagrandin I, in commercial teas. The inhibitory effect of commercial green and purple teas and purple tea ellagitannins was evaluated on α-glucosidase and α-amylase. The bioavailable urolithins were then investigated for additional antidiabetic effects, by evaluating their effect on cellular glucose uptake and lipid accumulation. RESULTS: Corilagin, strictinin and tellimagrandin I (ellagitannins) were identified as potent inhibitors of α-amylase and α-glucosidase, with Ki values significantly lower (p < 0.05) than acarbose. Commercial green-purple teas were identified as ellagitannin sources, with especially high concentrations of corilagin. These commercial purple teas, containing ellagitannins, were identified as potent α-glucosidase inhibitors with IC50 values significantly lower (p < 0.05) than green teas and acarbose. Urolithin A and urolithin B were as effective (p> 0.05) as metformin in increasing glucose uptake in adipocytes, muscle cells and hepatocytes. In addition, similar (p > 0.05) to metformin, both urolithin A and urolithin B reduced lipid accumulation in adipocytes and hepatocytes. CONCLUSIONS: This study identified green-purple teas as an affordable widely available natural source with antidiabetic properties. Furthermore, additional antidiabetic effects of purple tea ellagitannins (corilagin, strictinin and tellimagrandin I) and urolithins were identified.


Asunto(s)
Taninos Hidrolizables , Hipoglucemiantes , , Taninos Hidrolizables/análisis , Taninos Hidrolizables/farmacología , Hipoglucemiantes/farmacología , Té/química
2.
Pa Nurse ; 44(7): 15, 1989 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2748186
3.
Pa Nurse ; 45(8): 14, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2381727
4.
Dis Colon Rectum ; 34(3): 244-8, 1991 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1999131

RESUMEN

Clostridium difficile infection manifests as a self-limiting diarrhea, protracted colitis, or toxic pseudomembranous colitis. The incidence of C. difficile in a 514-bed community hospital was studied retrospectively; 155 patients of a total 18,262 admitted during 1988 were identified with C. difficile as an admitting or subsequent diagnosis. The method of diagnosis, mode of therapy, and related costs were analyzed. We have determined that education, with an emphasis on pathogenesis and prevention, is necessary to reduce the incidence in the hospital and the cost to the patient.


Asunto(s)
Clostridioides difficile , Infecciones por Clostridium/economía , Colitis/economía , Infección Hospitalaria/economía , Adulto , Antibacterianos/uso terapéutico , Técnicas Bacteriológicas/economía , Infecciones por Clostridium/diagnóstico , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/epidemiología , Colitis/diagnóstico , Colitis/tratamiento farmacológico , Colitis/epidemiología , Costos y Análisis de Costo , Infección Hospitalaria/diagnóstico , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/epidemiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
5.
Nursing ; 22(5): 8, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1584502
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA